105 related articles for article (PubMed ID: 8592948)
1. Intact parathyroid hormone levels are not elevated in glucocorticoid-treated subjects.
Paz-Pacheco E; Fuleihan GE; LeBoff MS
J Bone Miner Res; 1995 Nov; 10(11):1713-8. PubMed ID: 8592948
[TBL] [Abstract][Full Text] [Related]
2. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
3. Low dose prednisone does not affect calcium homeostasis or bone density in postmenopausal women with rheumatoid arthritis.
Leboff MS; Wade JP; Mackowiak S; el-Hajj Fuleihan G; Zangari M; Liang MH
J Rheumatol; 1991 Mar; 18(3):339-44. PubMed ID: 1856804
[TBL] [Abstract][Full Text] [Related]
4. Recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis: 2001 update. American College of Rheumatology Ad Hoc Committee on Glucocorticoid-Induced Osteoporosis.
Arthritis Rheum; 2001 Jul; 44(7):1496-503. PubMed ID: 11465699
[TBL] [Abstract][Full Text] [Related]
5. Bone density threshold and other predictors of vertebral fracture in patients receiving oral glucocorticoid therapy.
Van Staa TP; Laan RF; Barton IP; Cohen S; Reid DM; Cooper C
Arthritis Rheum; 2003 Nov; 48(11):3224-9. PubMed ID: 14613287
[TBL] [Abstract][Full Text] [Related]
6. Sex hormones and bone metabolism in postmenopausal rheumatoid arthritis treated with two different glucocorticoids.
Montecucco C; Caporali R; Caprotti P; Caprotti M; Notario A
J Rheumatol; 1992 Dec; 19(12):1895-900. PubMed ID: 1294736
[TBL] [Abstract][Full Text] [Related]
7. Relationship between endogenous parathyroid hormone and bone metabolism/geometry in female patients treated with glucocorticoid.
Kaji H; Yamauchi M; Chihara K; Sugimoto T
Horm Metab Res; 2008 Jan; 40(1):60-5. PubMed ID: 18072075
[TBL] [Abstract][Full Text] [Related]
8. Secondary hyperparathyroidism due to hypovitaminosis D affects bone mineral density response to alendronate in elderly women with osteoporosis: a randomized controlled trial.
Barone A; Giusti A; Pioli G; Girasole G; Razzano M; Pizzonia M; Palummeri E; Bianchi G
J Am Geriatr Soc; 2007 May; 55(5):752-7. PubMed ID: 17493196
[TBL] [Abstract][Full Text] [Related]
9. Assessment of bone metabolism and mineral density in chronic viral hepatitis.
Yenice N; Gümrah M; Mehtap O; Kozan A; Türkmen S
Turk J Gastroenterol; 2006 Dec; 17(4):260-6. PubMed ID: 17205403
[TBL] [Abstract][Full Text] [Related]
10. Effects of vitamin K2 in hemodialysis patients with low serum parathyroid hormone levels.
Nakashima A; Yorioka N; Doi S; Masaki T; Ito T; Harada S
Bone; 2004 Mar; 34(3):579-83. PubMed ID: 15003806
[TBL] [Abstract][Full Text] [Related]
11. [Determination of intact parathyroid hormone in patients with calcium metabolism disorders].
Birkeland KI; Falch JA; Gautvik KM; Gjestvang FT; Holst N; Haug E
Tidsskr Nor Laegeforen; 1991 Jun; 111(15):1840-4. PubMed ID: 1853314
[TBL] [Abstract][Full Text] [Related]
12. Episodic secretion of parathyroid hormone in postmenopausal women: assessment by deconvolution analysis and approximate entropy.
Samuels MH; Veldhuis JD; Kramer P; Urban RJ; Bauer R; Mundy GR
J Bone Miner Res; 1997 Apr; 12(4):616-23. PubMed ID: 9101373
[TBL] [Abstract][Full Text] [Related]
13. Quality assurance study of the use of preventative therapies in glucocorticoid-induced osteoporosis in early inflammatory arthritis: results from the CATCH cohort.
McKeown E; Bykerk VP; De Leon F; Bonner A; Thorne C; Hitchon CA; Boire G; Haraoui B; Ferland DS; Keystone EC; Pope JE;
Rheumatology (Oxford); 2012 Sep; 51(9):1662-9. PubMed ID: 22539481
[TBL] [Abstract][Full Text] [Related]
14. Chronic glucocorticoid treatment alters spontaneous pulsatile parathyroid hormone secretory dynamics in human subjects.
Bonadonna S; Burattin A; Nuzzo M; Bugari G; Rosei EA; Valle D; Iori N; Bilezikian JP; Veldhuis JD; Giustina A
Eur J Endocrinol; 2005 Feb; 152(2):199-205. PubMed ID: 15745926
[TBL] [Abstract][Full Text] [Related]
15. Elevated 1,25-dihydroxyvitamin D levels in patients with chronic obstructive pulmonary disease treated with prednisone.
Bikle DD; Halloran B; Fong L; Steinbach L; Shellito J
J Clin Endocrinol Metab; 1993 Feb; 76(2):456-61. PubMed ID: 8432789
[TBL] [Abstract][Full Text] [Related]
16. Prevention of corticosteroid-induced osteoporosis by alfacalcidol.
Lakatos P; Nagy Z; Kiss L; Horvath C; Takacs I; Foldes J; Speer G; Bossanyi A
Z Rheumatol; 2000; 59 Suppl 1():48-52. PubMed ID: 10769437
[TBL] [Abstract][Full Text] [Related]
17. Role of the oral calcium-loading test with measurement of intact parathyroid hormone in the diagnosis of symptomatic subtle primary hyperparathyroidism.
Monchik JM; Lamberton RP; Roth U
Surgery; 1992 Dec; 112(6):1103-9; discussion 1109-10. PubMed ID: 1455312
[TBL] [Abstract][Full Text] [Related]
18. Intestinal calcium absorption and parathyroid hormone secretion in asthmatic patients on prolonged oral or inhaled steroid treatment.
Luengo M; Picado C; Piera C; Guañabens N; Montserrat JM; Rivera J; Setoain J
Eur Respir J; 1991 Apr; 4(4):441-4. PubMed ID: 1855573
[TBL] [Abstract][Full Text] [Related]
19. Biochemical hyperparathyroidism and bone mineral status in patients treated long-term with lithium.
Nordenström J; Elvius M; Bågedahl-Strindlund M; Zhao B; Törring O
Metabolism; 1994 Dec; 43(12):1563-7. PubMed ID: 7990712
[TBL] [Abstract][Full Text] [Related]
20. Serum intact parathyroid hormone concentration measured by a two-site immunoradiometric assay in normal subjects and patients with various parathyroid disorders.
Okazaki R; Matsumoto T; Furukawa Y; Fujimoto Y; Niimi H; Seino Y; Fujita T; Nagataki S; Ogata E
Endocrinol Jpn; 1992 Feb; 39(1):115-20. PubMed ID: 1606913
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
